Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza. Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire - Years 2 (2010) & 3 (2011)
Latest Information Update: 26 Apr 2017
Price :
$35 *
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms SLVP017
- 18 Jan 2017 New trial record